SCHEMBL8166125

SCHEMBL8166125

COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1C(C(N)=O)c1c[nH]c2ccc(NC(=O)OC3CCCC3)cc12

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G4A P47712 5/20 0.59
CYSLTR2 Q9NS75 4/20 0.59
CYSLTR1 Q9Y271 4/20 0.59
MEN1 O00255 1/20 0.59
PTGES O14684 1/20 0.59
XPO1 O14980 1/20 0.59
SLC22A2 O15244 1/20 0.59
ABCC4 O15439 1/20 0.59
NR1I2 O75469 1/20 0.59
ABCB11 O95342 1/20 0.59
EGFR P00533 1/20 0.59
NR3C1 P04150 1/20 0.59
PGR P06401 1/20 0.59
POLB P06746 1/20 0.59
ADRA2A P08913 1/20 0.59
ADORA3 P0DMS8 1/20 0.59
MAPT P10636 1/20 0.59
RARB P10826 1/20 0.59
CYP2C9 P11712 1/20 0.59
CNR1 P21554 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8153771 0.93 PLA2G4A (0.59) PLA2G4ACYSLTR2CYSLTR1MEN1PTGES
SCHEMBL8429368 0.92 PLA2G4A (0.58) PLA2G4ACYSLTR2CYSLTR1MEN1PTGES
SCHEMBL8427261 0.91 PLA2G4A (0.57) PLA2G4ACYSLTR2CYSLTR1MEN1PTGES
SCHEMBL4117791 0.91 PLA2G4A (0.61) PLA2G4ACYSLTR2CYSLTR1MEN1PTGES
SCHEMBL8425063 0.91 PLA2G4A (0.58) PLA2G4ACYSLTR2CYSLTR1MEN1PTGES
SCHEMBL8425048 0.91 PLA2G4A (0.57) PLA2G4ACYSLTR2CYSLTR1MEN1PTGES
SCHEMBL8951207 0.90 PLA2G4A (0.61) PLA2G4ACYSLTR2CYSLTR1MEN1PTGES
SCHEMBL8425034 0.90 CYSLTR2 (0.57) PLA2G4ACYSLTR2CYSLTR1MEN1PTGES
SCHEMBL8425281 0.90 PLA2G4A (0.59) PLA2G4ACYSLTR2CYSLTR1MEN1PTGES
SCHEMBL8161239 0.89 PLA2G4A (0.59) PLA2G4ACYSLTR2CYSLTR1MEN1PTGES

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-3020612-B2 2000-03-15 JP claimed
EP-0863873-B1 INDOLE CARBAMATES AS LEUKOTRIENE ANTAGONISTS PFIZER (US) 1999-11-10 EP claimed
US-5965745-A ASTHMA; ANTIARTHRITIC,-SHOCK AGENTS; BRONCHITIS; RESPIRATORY SYSTEM DISEASES, E.G. CHRONIC OBSTRUCTIVE AIRWAYS DISEASES; PSORIASIS; ALLERGIC RHINITIS; ATOPIC DERMATITIS PFIZER INC (US) 1999-10-12 US claimed
EP-0863873-A1 INDOLE CARBAMATES AS LEUKOTRIENE ANTAGONISTS PFIZER INC. (US) 1998-09-16 EP claimed
WO-1997013751-A1 INDOLE CARBAMATES AS LEUKOTRIENE ANTAGONISTS PFIZER INC. (US) 1997-04-17 WO claimed
EP-0863873-B1 INDOLE CARBAMATES AS LEUKOTRIENE ANTAGONISTS PFIZER (US) 1999-11-10 EP disclosed
US-5965745-A ASTHMA; ANTIARTHRITIC,-SHOCK AGENTS; BRONCHITIS; RESPIRATORY SYSTEM DISEASES, E.G. CHRONIC OBSTRUCTIVE AIRWAYS DISEASES; PSORIASIS; ALLERGIC RHINITIS; ATOPIC DERMATITIS PFIZER INC (US) 1999-10-12 US disclosed
EP-0863873-A1 INDOLE CARBAMATES AS LEUKOTRIENE ANTAGONISTS PFIZER INC. (US) 1998-09-16 EP disclosed
WO-1997013751-A1 INDOLE CARBAMATES AS LEUKOTRIENE ANTAGONISTS PFIZER INC. (US) 1997-04-17 WO disclosed